Clopra and Bronchiectasis - a phase IV clinical study of FDA data

Summary:

Bronchiectasis is reported as a side effect among people who take Clopra (metoclopramide hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Acetaminophen, and have Interstitial lung disease.

The phase IV clinical study analyzes which people have Bronchiectasis when taking Clopra. It is created by eHealthMe based on reports of 80,974 people who have side effects when taking Clopra from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Bronchiectasis?

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 784 drugs and 857 conditions by eHealthMe. Check the latest studies of Bronchiectasis.

On Jul, 18, 2026

80,974 people reported to have side effects when taking Clopra.
Among them, 37 people (0.05%) have Bronchiectasis.

Among these 37 people:

How long have people been on Clopra when they have Bronchiectasis? *

What is the gender of people who have Bronchiectasis when taking Clopra? *

female: 29.03 %
male: 70.97 %

What is the age of people who have Bronchiectasis when taking Clopra? *

What are other drugs people take besides Clopra? *

What are other side effects people have besides Bronchiectasis? *

Dyspnea (difficult or laboured breathing): 17 people, 45.95%
Pneumonia: 15 people, 40.54%
Nausea (feeling of having an urge to vomit): 15 people, 40.54%
Cough: 14 people, 37.84%
Fatigue (feeling of tiredness): 12 people, 32.43%
Diarrhea: 12 people, 32.43%
Nausea And Vomiting: 11 people, 29.73%
Oxygen Saturation Decreased: 11 people, 29.73%
Rales (an abnormal respiratory sound characterized by fine crackles): 10 people, 27.03%
Nosebleed (bleeding from nose): 10 people, 27.03%

What are the existing conditions these people have? *

Interstitial Lung Disease: 10 people, 27.03%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 8 people, 21.62%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 7 people, 18.92%
Nausea And Vomiting: 5 people, 13.51%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.51%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 10.81%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 10.81%
Nausea (feeling of having an urge to vomit): 4 people, 10.81%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 8.11%
High Blood Pressure: 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Bronchiectasis?

- Check whether Bronchiectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopra:

Clopra (81,430 reports)

Bronchiectasis treatments and more:

Bronchiectasis (12,460 reports)

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchiectasis:

Bronchiectasis (784 drugs)

Browse all the conditions that are associated with Bronchiectasis:

Bronchiectasis (857 conditions)

Related publications that referenced our studies

Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Clopra) and Clopra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.